Silk Road Medical Inc. Stock News

SUNNYVALE, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the appointm

APG, FLR, ROCK, SILK, and CYD have been added to the Zacks Rank #5 (Strong Sell) List on March 25, 2021

Silk Road Medical (SILK) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front

Bear of the Day: Silk Road Medical (SILK)

Silk Road Medical, Inc's (SILK) CEO Erica Rogers on Q4 2020 Results - Earnings Call Transcript

Silk Road Medical (SILK) delivered earnings and revenue surprises of -63.33% and -0.51%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Shares of Silk Road Medical (NASDAQ:SILK) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share fell 70.37% over the past year to ($0.46), which

Submitted PMA Supplement for ENROUTE Stent in Standard Surgical Risk Patients

Silk Road Medical (SILK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SUNNYVALE, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report

New York, New York--(Newsfile Corp. - February 15, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc. ("Silk Road" or the "Company") (NASDAQ: SILK). Such i

New York, New York--(Newsfile Corp. - February 11, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc. ("Silk Road" or the "Company") (NASDAQ: SILK). Such i

Silk Road Medical has delivered resilient operational growth in recent times, even amidst Covid-19. I like the product and the growth, yet it seems that 2020s price action reflects quite some good new

New York, New York--(Newsfile Corp. - February 6, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc. ("Silk Road" or the "Company") (NASDAQ: SILK). Such in

NEW YORK, Feb. 5, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc. ("Silk Road" or the "Company") (NASDAQ: SILK). Such investors are advised